Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: Role of physical exercise

Circulation

Volumn 96, Issue 8, 1997, Pages 2534-2541

  Niebauer, Josef ^a,d   Hambrecht, Rainer ^b   Velich, Tamás ^a   Hauer, Klaus ^a   Marburger, Christian ^a   Kälberer, Barbara ^a   Weiss, Claus ^a   Von Hodenberg, Eberhard ^c   Schlierf, Günter ^a   Schuler, Gerhard ^b   Zimmermann, Rainer ^a   Kübler, Wolfgang ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Medizinische Klinik   (Germany)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Angiography; Atherosclerosis; Diet; Exercise; Prevention

Indexed keywords

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE; HUMAN; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; WORK CAPACITY;

EID: 18544394788     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2534     Document Type: Article

References (40)

1. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, DeBoer LWV, Mahrer PR. Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ, and the MARS Research Group. Coronary angiographic changes with lovastatin therapy. Ann Intern Med. 1993;119:969-976.
2. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, Farquhar JW. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994;89: 975-990.
3. Jukema JW, Bruschke AVG, van Boven AJ, Reiber JHC, Bal ET, Zwinderman AH, Jansen H, Boerma GJM, van Rappard FM, Lie KI, on behalf of the REGRESS Study Group. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the REgression GRowth Evaluation Statin Study (REGRESS). Circulation. 1995;91:2528-2540.
4. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993; 87:1781-1791.
5. Scandinavian 4S Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
6. Sacks FM, Pfeffer MA, Lemuel AM, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C-C, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (CARE trial). N Engl J Med. 1996;335:1001-1009.
7. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens CH. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;80:234-244.
8. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA. 1988;260:945-950.
9. Fletcher G, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, Froelicher ESS, Froelicher VF, Pina IL, Pollock ML. Statement on exercise: benefits and recommendations for physical activity programs for all Americans: a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1996;94:857-862.
10. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand R, Gould KI. Can lifestyle changes reverse coronary heart disease? Lancet. 1990;336: 129-133.
11. Gould KL, Ornish D, Scherwitz L, Brown S, Edens P, Hess MJ, Mullani N, Bolomey L, Dobbs F, Armstrong WT, Merritt T, Ports T, Sparler S, Billings J. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995;274:894-901.
12. Gotto AM Jr, Bierman EL, Connor WE, Ford CH, Frantz JD Jr, Glueck CJ, Grundy SM, Little JA. American Heart Association Special Report: recommendations for the treatment of hyperlipidemia in adults. Circulation. 1984;69:1065A-1090A.
13. Schuler G, Hamhrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J, Hoberg E, Drinkmann A, Bacher F, Grunze M, Kübler W. Regular physical exercise and low fat diet: effects on progression of coronary artery disease. Circulation. 1992;86:1-11.
14. Niebauer J, Hambrecht R, Velich T, Marburger C, Hauer K, Kreuzer J, Zimmermann R, von Hodenberg E, Schlierf G, Schuler G. Kübler W. Predictive value of lipid profile for salutary coronary angiographie changes in patients on a low fat diet and physical exercise program. Am J Cardiol. 1996;78:163-167.
15. Hambrecht R, Niebauer J, Marburger C, Grunze M, Kälberer B, Hauer K, Schlierf G, Kübler W, Schuler G. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol. 1993;22:468-477.
16. Niebauer J, Hambrecht R, Kauer K, Marburger C, Schöppenthau M, Kälberer B, Schlierf G, Kübler W, Schuler G. Identification of patients at risk during swimming by Holter monitoring. Am J Cardiol. 1994;74:651-656.
17. Niebauer J, Hambrecht R, Marburger C, Hauer K, Velich T, von Hodenberg E, Schlierf G, Kübler W, Schuler G. Impact of intensive physical exercise and low fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease. Am J Cardiol. 1995;76:771-775.
18. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of prudent weight-reducing diet, with or without exercise in overweight men and women. N Engl J Med. 1991;325:461-466.
19. Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, Mann JI, Swan AV. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerotic Regression Study (STARS). Lancet. 1992;339:563-569.
20. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
21. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoprotein in a prospective survey of coronary artery disease in men. Am J Cardiol. 1992;69:1251-1254.
22. Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE. Apolipoproteins and ischemic heart disease: implications for screening. Lancet. 1994;343:75-79.
23. Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol. 1996;28:1652-1660.
24. Berdeaux A, Ghaleh B, Dubois-Rande JL, Vigue B, Drieu La Rochelle C, Hittinger L, Giudicelli JF. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation. 1994;89:2799-2808.
25. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
26. Tsao PS, Buitrago R, Chan JR, Cooke JP. Fluid flow inhibits endothelial adhesiveness and transcriptional replication of VCAM-1. Circulation. 1996;94:1682-1689.
27. Yao S, Ober JC, Krishnaswami AK, Ferguson JJ, Anderson HV, Lokino P, Buha KM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 1992;86: 1302-1309.
28. Bath PMW, Hassall DG, Gladwin A-M, Palmer RMJ, Martin JF. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11:254-260.
29. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
30. Wang B, Singer AH, Tsao P, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol. 1994;23:452-458.
31. Candipan RC, Wang B-Y, Buitrago R, Tsao PS, Cooke JP. Regression or progression: dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol. 1996;16:44-50.
32. Peng HB, Rajavashisth TB, Libby P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem. 1995;270:17050-17055.
33. Marui N, Offerman MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
34. Heaton WH, Marr KC, Capurro NL, Goldstein RE, Epstein SE. Beneficial effect of physical training on blood flow to myocardium perfused by chronic collaterals in the exercising dog. Circulation. 1978;57:575-581.
35. Nolewajka AJ, Kostuk WJ, Rechnitzer PA, Cunningham DA. Exercise and human collateralization: an angiographic and scintigraphic assessment. Circulation. 1979;60:114-121.
36. Ferguson RJ, Petitclerc R, Choquette G, Chaniotis L, Gauthier P, Huot R, Allard C, Jankowski L, Campeau L. Effect of physical training on treadmill exercise capacity, collateral circulation and progression of coronary disease. Am J Cardiol. 1974;34:764-769.
37. Schaper W. Influence of physical exercise on coronary collateral blood flow in chronic experimental two-vessel occlusion. Circulation. 1982;65:905-912.
38. Ehsani AA, Heath GW, Hagberg JM, Sobel BE, Holloszy JO. Effects of 12 months of intense exercise training on ischemic ST-segment depression in patients with coronary artery disease. Circulation. 1981;64:1116-1124.
39. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med. 1993;329:1677-1683.
40. Willich SN, Lewis M, Lowel H, Arntz HR, Schubert F, Schroder R. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med. 1993;329:1684-1690.